Helium Supply Agreement: Market participants have highlighted a five-year take-or-pay contract for high-purity helium from the Virginia Gas Project, linking the supply to semiconductor manufacturing needs. The deal at premium pricing above $600 per MCF signals buyer interest in securing non-traditional sources amid growing industrial demand. Observers note this positions the company within broader AI infrastructure constraints beyond typical chip-related plays.
Merger and Dilution Developments: Discussion has focused on a PIPE financing of Class A units at $6.57 ahead of a merger with Noble Africa Inc., the successor to ENDRA. Some view the structure as potentially supportive for valuation clarity post-transaction, while others flag share issuance as a near-term pressure point. Recent price action from higher levels to around $6 drew comments on possible short-selling activity amid the news flow.
Market Sentiment Overview: Traders point to relative resilience compared to broader tech indices despite macro headwinds, with key support levels cited near $6.88 to $7.00. The combination of contract wins and corporate restructuring has kept engagement elevated without triggering widespread breakout expectations.
Note: This discussion summary was generated from an AI condensation of post data.
ASP Isotopes Insider Trading Activity
ASP Isotopes insiders have traded $ASPI stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $ASPI stock by insiders over the last 6 months:
- PAUL ELLIOT MANN (Chairman and CEO) has made 0 purchases and 4 sales selling 413,428 shares for an estimated $2,885,800.
- ROBERT AINSCOW (COO) has made 0 purchases and 4 sales selling 64,376 shares for an estimated $334,839.
- HEATHER KIESSLING (Chief Financial Officer) sold 23,124 shares for an estimated $126,673
- DUNCAN MOORE sold 11,642 shares for an estimated $60,596
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ASP Isotopes Hedge Fund Activity
We have seen 115 institutional investors add shares of ASP Isotopes stock to their portfolio, and 94 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ENCOMPASS CAPITAL ADVISORS LLC added 6,912,054 shares (+inf%) to their portfolio in Q1 2026, for an estimated $30,551,278
- ALYESKA INVESTMENT GROUP, L.P. removed 2,203,380 shares (-45.0%) from their portfolio in Q1 2026, for an estimated $9,738,939
- CAPITAL RESEARCH GLOBAL INVESTORS removed 2,043,567 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $10,933,083
- VANGUARD GROUP INC added 1,889,481 shares (+41.8%) to their portfolio in Q4 2025, for an estimated $10,108,723
- BLACKROCK, INC. added 1,538,727 shares (+22.7%) to their portfolio in Q1 2026, for an estimated $6,801,173
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 1,419,837 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $7,596,127
- GOLDMAN SACHS GROUP INC removed 1,188,497 shares (-69.3%) from their portfolio in Q1 2026, for an estimated $5,253,156
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
